CoreAge Rx vs Iron Med RX
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Iron Med RX head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 46 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Iron Med RX a bad call — it's best for people comparing injection and oral options who want continuing clinician support and will verify the actual formulation, pharmacy and billing commitment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Iron Med RX |
|---|---|---|
| Brief Score | 94/100 (A) | 46/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Injection from $149/mo; full plan unconfirmed Oral catalog from $196/mo is a different format. Injection pages advertise care, messaging and free shipping with monthly/three-/six-month options; full supplied quantity, term payment and required fees unconfirmed. Refunds may narrow after review/approval/pharmacy processing, before delivery. Ineligibility remedy depends on services/fees, not guaranteed full refund; cancel future refills before their renewal. Full price detailsCompounded semaglutide injection offered; complete selected-plan quote unknown; injection from $149/month, oral tablet catalog from $196/month, monthly/three-/six-month injection plans advertised without full dose/supply or term payment |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Injection from $149/mo; full plan unconfirmed Oral catalog from $249/mo is a different format. Injection pages advertise care, messaging and free shipping with monthly/three-/six-month options; full supplied quantity, term payment and required fees unconfirmed. Refunds may narrow after review/approval/pharmacy processing, before delivery. Ineligibility remedy depends on services/fees, not guaranteed full refund; cancel future refills before their renewal. Full price detailsCompounded tirzepatide injection offered; complete selected-plan quote unknown; injection from $149/month, oral tablet catalog from $249/month, monthly/three-/six-month injection plans advertised without full dose/supply or term payment |
| Coverage | US only; restrictions by state, confirmed at intake | Clinician and pharmacy access depend on patient location; the reviewed offer does not establish a complete current state list |
| Brand-name access | Not confirmed | The reviewed current offers include compounded preparations; named branded GLP-1 prescribing was not established. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Iron Med RX: Injections from $149/month; oral catalog from $196 semaglutide/$249 tirzepatide. Full term/supply quote unconfirmed; care and shipping advertised. Refund restrictions can begin at provider approval or pharmacy processing.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.